Goodwill And Other Intangible Assets

3 Months Ended

Sep. 30, 2011

Goodwill And Other Intangible Assets [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

The Company performs its annual goodwill impairment test on the first day of its fiscal fourth quarter. In addition, if and when events or circumstances change that would more likely than not reduce the fair value of any of its reporting units below its carrying value, an interim test is performed.

Changes in the carrying amount of goodwill for the three months ended September 30, 2011 were as follows:


	Goodwill			Accumulated Impairment Losses			Net Carrying Value
Balance as of June 30, 2011:	$	610,403		$	(42,029	)	$	568,374
Translation adjustments, net		(5,164	)		—			(5,164	)

Balance as of September 30, 2011:	$	605,239		$	(42,029	)	$	563,210

Amounts assigned to indefinite-life intangible assets primarily represent the values of trademarks and tradenames. At September 30, 2011, included in trademarks and other intangible assets on the balance sheet are $54,670 of intangible assets deemed to have a finite life which are being amortized over their estimated useful lives of 3 to 20 years. The following table reflects the components of trademarks and other intangible assets:


	September 30, 2011			June 30, 2011

Non-amortized intangible assets:
Trademarks and tradenames	$	185,428		$	186,273
Amortized intangible assets:
Other intangibles		54,670			55,314
Less: accumulated amortization		(22,770	)		(21,158	)

Net carrying amount	$	217,328		$	220,429

Amortization expense for the three months ended September 30 was as follows:


	2011		2010
Amortization of intangible assets	$	1,776	$	1,602

Expected amortization expense over the next five fiscal years is as follows:


	2012		2013		2014		2015		2016
Estimated amortization expense	$	6,790	$	5,414	$	4,542	$	4,435	$	4,019

The weighted average remaining amortization period of amortized intangible assets is 6.7 years.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details